Articles

University of Southampton research shows significance of cancer specialist nursing care in hospital settings. Read More ›

Breast cancer is less likely to recur in women previously treated for the disease if they take adjuvant tamoxifen for 10 years instead of 5 years. Read More ›

Results from the phase 3 DECISION study showed that sorafenib significantly improved progression-free survival for patients with radioactive iodine–differentialted thyroid cancer. Read More ›

Data presented at ASCO showed that several drugs in early-stage testing show promise. These drugs unleash the body’s immune system to attack cancer cells much as it attacks bacteria. Read More ›

The results of several studies show new prospects for treating patients with advanced melanoma. Three novel strategies use the body’s immune system to attack melanomas. Read More ›

PSA testing of healthy men has been the subject of much debate and clinical practice guideline recommendations from professional organizations and clinical panels in the United States are not necessarily in total agreement. Read More ›

Fox Chase Cancer Center study reveals decreased bone metastasis pain when nerve endings are targeted. Read More ›

Massachusetts Institute of Technology study demonstrates potential of money-saving procedure. Read More ›

Clinical trials specifically targeting young patients with breast cancer are necessary. Read More ›

Dana-Farber Cancer Institute study involved breast cancer patients diagnosed at age ≤40 years. Read More ›